[15-12G] Third Harmonic Bio, Inc. SEC Filing
Third Harmonic Bio, Inc. submitted a Form 15 certifying termination of its registration under the Securities Exchange Act and suspension of periodic filing obligations. The company relied on Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i) and reported an approximate 6 holders of record. The notice was executed by Christopher Murphy, Chief Financial and Business Officer. This filing means the company will no longer be required to furnish periodic SEC reports under the Exchange Act, reducing the availability of routine public disclosures.
Third Harmonic Bio, Inc. ha presentato un Form 15 attestando la cessazione della propria registrazione ai sensi del Securities Exchange Act e la sospensione degli obblighi di deposito periodico. La società si è avvalsa di Rule 12g-4(a)(1) e Rule 12h-3(b)(1)(i) e ha riportato circa 6 titolari registrati. L'avviso è stato sottoscritto da Christopher Murphy, direttore finanziario e responsabile business. Tale deposito implica che la società non sarà più obbligata a fornire rapporti periodici alla SEC ai sensi dell'Exchange Act, riducendo la disponibilità delle divulgazioni pubbliche di routine.
Third Harmonic Bio, Inc. presentó un Form 15 que certifica la terminación de su registro bajo el Securities Exchange Act y la suspensión de las obligaciones de presentación periódica. La compañía se apoyó en Rule 12g-4(a)(1) y Rule 12h-3(b)(1)(i) y declaró tener aproximadamente 6 tenedores registrados. El aviso fue firmado por Christopher Murphy, Director Financiero y de Negocios. Esta presentación implica que la compañía ya no estará obligada a presentar informes periódicos ante la SEC conforme al Exchange Act, lo que reduce la disponibilidad de divulgaciones públicas rutinarias.
Third Harmonic Bio, Inc.는 증권거래법(Securities Exchange Act)에 따른 등록 해지 및 정기 제출 의무의 중단을 인증하는 Form 15를 제출했습니다. 회사는 Rule 12g-4(a)(1) 및 Rule 12h-3(b)(1)(i)를 근거로 했으며 기록상 약 6명의 보유자가 있다고 보고했습니다. 이 통지는 최고재무 및 사업책임자(Chief Financial and Business Officer)인 Christopher Murphy가 실행했습니다. 이번 제출로 회사는 더 이상 Exchange Act에 따라 SEC에 정기 보고서를 제출할 의무가 없어져 일상적인 공시의 이용 가능성이 감소합니다.
Third Harmonic Bio, Inc. a déposé un Form 15 certifiant la cessation de son enregistrement au titre du Securities Exchange Act et la suspension de ses obligations de dépôt périodique. La société s'est appuyée sur Rule 12g-4(a)(1) et Rule 12h-3(b)(1)(i) et a déclaré compter environ 6 titulaires enregistrés. L'avis a été signé par Christopher Murphy, directeur financier et commercial. Ce dépôt signifie que la société ne sera plus tenue de fournir des rapports périodiques à la SEC en vertu de l'Exchange Act, ce qui réduit la disponibilité des divulgations publiques de routine.
Third Harmonic Bio, Inc. hat ein Form 15 eingereicht, das die Beendigung ihrer Registrierung nach dem Securities Exchange Act und die Aussetzung der periodischen Meldepflichten bescheinigt. Das Unternehmen stützte sich auf Rule 12g-4(a)(1) und Rule 12h-3(b)(1)(i) und gab an, etwa 6 eingetragene Inhaber zu haben. Die Mitteilung wurde von Christopher Murphy, Finanz- und Geschäftsleiter, unterzeichnet. Durch diese Einreichung ist das Unternehmen nicht mehr verpflichtet, regelmäßig Berichte bei der SEC gemäß dem Exchange Act einzureichen, wodurch die Verfügbarkeit routinemäßiger öffentlicher Offenlegungen eingeschränkt wird.
- None.
- None.
Insights
TL;DR Deregistration under Form 15 ends routine SEC reporting, materially reducing public disclosure and shareholder transparency.
The company certified termination under Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i), reporting only six holders of record. From a governance perspective, ending periodic reporting removes regular audited and unaudited disclosures that investors rely on for oversight. While the filing is a formal compliance action, it materially changes the transparency profile and information flow available to shareholders.
TL;DR Form 15 filing suspends reporting obligations and signals a shift to reduced SEC disclosure for THRD.
Third Harmonic Bio's reliance on the cited rules and the small number of record holders (6) enables termination of its reporting duties. For market participants, this means fewer public periodic filings to track operating results, financial condition, and other material developments. The change is material for investors who depend on Exchange Act reports for timely company information.
Third Harmonic Bio, Inc. ha presentato un Form 15 attestando la cessazione della propria registrazione ai sensi del Securities Exchange Act e la sospensione degli obblighi di deposito periodico. La società si è avvalsa di Rule 12g-4(a)(1) e Rule 12h-3(b)(1)(i) e ha riportato circa 6 titolari registrati. L'avviso è stato sottoscritto da Christopher Murphy, direttore finanziario e responsabile business. Tale deposito implica che la società non sarà più obbligata a fornire rapporti periodici alla SEC ai sensi dell'Exchange Act, riducendo la disponibilità delle divulgazioni pubbliche di routine.
Third Harmonic Bio, Inc. presentó un Form 15 que certifica la terminación de su registro bajo el Securities Exchange Act y la suspensión de las obligaciones de presentación periódica. La compañía se apoyó en Rule 12g-4(a)(1) y Rule 12h-3(b)(1)(i) y declaró tener aproximadamente 6 tenedores registrados. El aviso fue firmado por Christopher Murphy, Director Financiero y de Negocios. Esta presentación implica que la compañía ya no estará obligada a presentar informes periódicos ante la SEC conforme al Exchange Act, lo que reduce la disponibilidad de divulgaciones públicas rutinarias.
Third Harmonic Bio, Inc.는 증권거래법(Securities Exchange Act)에 따른 등록 해지 및 정기 제출 의무의 중단을 인증하는 Form 15를 제출했습니다. 회사는 Rule 12g-4(a)(1) 및 Rule 12h-3(b)(1)(i)를 근거로 했으며 기록상 약 6명의 보유자가 있다고 보고했습니다. 이 통지는 최고재무 및 사업책임자(Chief Financial and Business Officer)인 Christopher Murphy가 실행했습니다. 이번 제출로 회사는 더 이상 Exchange Act에 따라 SEC에 정기 보고서를 제출할 의무가 없어져 일상적인 공시의 이용 가능성이 감소합니다.
Third Harmonic Bio, Inc. a déposé un Form 15 certifiant la cessation de son enregistrement au titre du Securities Exchange Act et la suspension de ses obligations de dépôt périodique. La société s'est appuyée sur Rule 12g-4(a)(1) et Rule 12h-3(b)(1)(i) et a déclaré compter environ 6 titulaires enregistrés. L'avis a été signé par Christopher Murphy, directeur financier et commercial. Ce dépôt signifie que la société ne sera plus tenue de fournir des rapports périodiques à la SEC en vertu de l'Exchange Act, ce qui réduit la disponibilité des divulgations publiques de routine.
Third Harmonic Bio, Inc. hat ein Form 15 eingereicht, das die Beendigung ihrer Registrierung nach dem Securities Exchange Act und die Aussetzung der periodischen Meldepflichten bescheinigt. Das Unternehmen stützte sich auf Rule 12g-4(a)(1) und Rule 12h-3(b)(1)(i) und gab an, etwa 6 eingetragene Inhaber zu haben. Die Mitteilung wurde von Christopher Murphy, Finanz- und Geschäftsleiter, unterzeichnet. Durch diese Einreichung ist das Unternehmen nicht mehr verpflichtet, regelmäßig Berichte bei der SEC gemäß dem Exchange Act einzureichen, wodurch die Verfügbarkeit routinemäßiger öffentlicher Offenlegungen eingeschränkt wird.
FAQ
What action did Third Harmonic Bio (THRD) take in this filing?
Which rules did Third Harmonic Bio rely on to terminate reporting?
How many holders of record did THRD report?
Who signed the Form 15 for Third Harmonic Bio?
Does this filing mean THRD no longer provides SEC reports?
